Context Therapeutics Inc.
CNTX
$1.52
-$0.19-11.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -40.23M | -36.12M | -26.44M | -34.21M | -27.63M |
| Total Depreciation and Amortization | 17.00K | 16.40K | 15.20K | 13.90K | 12.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.56M | 3.44M | 1.34M | 15.97M | 15.71M |
| Change in Net Operating Assets | 3.86M | 6.28M | 2.73M | 517.80K | -3.32M |
| Cash from Operations | -32.79M | -26.39M | -22.35M | -17.70M | -15.22M |
| Capital Expenditure | -37.30K | -33.90K | -33.90K | -41.20K | -41.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.00M | -2.00M | 0.00 | -14.75M | -14.75M |
| Cash from Investing | -2.04M | -2.03M | -33.90K | -14.79M | -14.79M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 14.54M | 14.54M | 109.34M |
| Repurchase of Common Stock | -- | -- | -- | -44.60K | -44.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -15.30K | -15.30K | -15.30K | -15.30K |
| Cash from Financing | 0.00 | -15.30K | 14.52M | 14.48M | 109.28M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.82M | -28.43M | -7.86M | -18.02M | 79.26M |